Search Results - "Jansz, P"

Refine Results
  1. 1

    Increasing the Tolerance of DCD Hearts to Warm Ischemia by Pharmacological Postconditioning by Iyer, A., Gao, L., Doyle, A., Rao, P., Jayewardene, D., Wan, B., Kumarasinghe, G., Jabbour, A., Hicks, M., Jansz, P. C., Feneley, M. P., Harvey, R. P., Graham, R. M., Dhital, K. K., Macdonald, P. S.

    Published in American journal of transplantation (01-08-2014)
    “…Donation after circulatory death (DCD) offers a potential additional source of cardiac allografts. We used a porcine asphyxia model to evaluate viability of…”
    Get full text
    Journal Article
  2. 2

    Vasopressor Requirement in Patients Undergoing Ventricular Assist Device Explant and Heart Transplant by Emmanuel, S., Pearman, M., Jansz, P., Hayward, C.

    “…Vasoplegia post ventricular assist device (VAD) explant and heart transplantation is a well recognised phenomenon. One potential reason for this is the…”
    Get full text
    Journal Article
  3. 3

    First in Man Anatomical Fitting Study of the BiVACOR Total Artificial Heart by Emmanuel, S., Watson, A., Connellan, M., Granger, E., Jansz, P., Timms, D., Hayward, C.

    “…BiVACOR is a new and novel total artificial heart utilising a single centrifugal magnetically levitated motor featuring a pulsatile flow. The device has been…”
    Get full text
    Journal Article
  4. 4

    Outpatient Management of Intra‐Corporeal Left Ventricular Assist Device System in Children: A Multi‐Center Experience by Schweiger, M., Vanderpluym, C., Jeewa, A., Canter, C. E., Jansz, P., Parrino, P. E., Miera, O., Schmitto, J., Mehegan, M., Adachi, I., Hübler, M., Zimpfer, D.

    Published in American journal of transplantation (01-02-2015)
    “…Little is known about the outcomes of children supported on intracorporeal left ventricular assist device (HVAD), and the feasibility of outpatient management…”
    Get full text
    Journal Article
  5. 5

    Normothermic Ex Vivo Perfusion Provides Superior Organ Preservation and Enables Viability Assessment of Hearts From DCD Donors by Iyer, A., Gao, L., Doyle, A., Rao, P., Cropper, J. R., Soto, C., Dinale, A., Kumarasinghe, G., Jabbour, A., Hicks, M., Jansz, P. C., Feneley, M. P., Harvey, R. P., Graham, R. M., Dhital, K. K., MacDonald, P. S.

    Published in American journal of transplantation (01-02-2015)
    “…The shortage of donors in cardiac transplantation may be alleviated by the use of allografts from donation after circulatory death (DCD) donors. We have…”
    Get full text
    Journal Article
  6. 6

    Hypertension, Arterial Compliance and LVAD Pump Function by Adji, A., Shehab, S., Jain, P., Robson, D., Jansz, P., Hayward, C.

    “…Hypertension (HTN) has been implicated as a risk factor for stroke in continuous-flow Left Ventricular Assist Device (LVAD) populations. Active treatment of…”
    Get full text
    Journal Article
  7. 7

    Pump Thrombosis, Scratching the Surface by Robson, D., Schnegg, B., Fattore, J., Jansz, P., Muthiah, K., Hayward, C.

    “…Pump thrombosis (PT) remains a serious complication in patients supported with a ventricular assist device (VAD). In our institution, HeartWare HVAD patients…”
    Get full text
    Journal Article
  8. 8

    Enhanced Preservation of Pig Cardiac Allografts by Combining Erythropoietin With Glyceryl Trinitrate and Zoniporide by Watson, A. J., Gao, L., Sun, L., Tsun, J., Doyle, A., Faddy, S. C., Jabbour, A., Orr, Y., Dhital, K., Hicks, M., Jansz, P. C., Macdonald, P. S.

    Published in American journal of transplantation (01-07-2013)
    “…Erythropoietin has a tissue‐protective effect independent of its erythropoietic effect that may be enhanced by combining it with the nitric oxide donor…”
    Get full text
    Journal Article
  9. 9
  10. 10
  11. 11

    Getting the Time Right: What Matters, What Doesn't, and How Should We Really Be Defining Ischemic Times in DCD Withdrawals? by Scheuer, S.E., Chew, H.C., Soto, C., Hicks, M., Gao, L., Villanueva, J., Kawanishi, Y., Watson, A., Connellan, M., Granger, E.K., Jansz, P.C., Macdonald, P.S.

    “…Over 100 DCD heart transplants have now been performed worldwide, with excellent early and mid-term results. However, there is a high degree of variability…”
    Get full text
    Journal Article
  12. 12
  13. 13

    In vivo tissue reaction within the outflow conduit in patients supported by HeartWare HVAD by Jain, P., Robson, D., Shehab, S., Muthiah, K., Jansz, P., Qiu, M.R., Barrett, W., Sivasubramaniam, V., Kumaradevan, N., Macdonald, P.S., Hayward, C.S.

    Published in Cardiovascular pathology (01-01-2020)
    “…The frequency, extent, and nature of tissue ingrowth within the continuous-flow left ventricular assist device (cf-LVAD) outflow conduit has not been…”
    Get full text
    Journal Article
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20